World Wires · story 17035 · unverified · 1 source(s)

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company

Open in the desk

Coverage

• Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire: public companies · tier D · clear net · 2026-10-02 20:05 UTC

What this site indexes